INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...

VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...

Most efforts were directed at pharmacological agents, which modify the molecular structure of the vitreous and its attachment to the retina ... adhesion and macular hole. The anatomy and ...

In this Healio Video Perspective from Hawaiian Eye 2025, Richard Small, CEO of Neurotech Pharmaceuticals, discusses the ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

and diabetic macular edema (DME). In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the ...

Jan. 14, 2025 — Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading ...

The American Optometric Association points to omega-3s as a nutrient that can slow the progress of age-related macular degeneration. Studies have also found that they can help prevent dry eye disease.